FDA approves ViiV Healthcare’s Juluca for maintenance treatment of HIV-1

ViiV Healthcare, a joint venture between GlaxoSmithKline (GSK), Pfizer, and Shionogi, has received approval from the U.S. Food and Drug Administration (FDA) for its two-drug ... Read More